COMMUNIQUÉS West-GlobeNewswire

Best Kratom Brand: Happy Go Leafy, Ranked #1 Kratom Vendor by Plastic Surgery Key
15/09/2025
Plastic Surgery Key’s recent annual kratom vendors ranking 2025 placed Happy Go Leafy at the top, citing product quality, strain variety, and other factors. Read more. Miami, Florida, Sept. 15, 2025 (GLOBE NEWSWIRE) -- [...]
Successful Commercial Launch of Ryoncil® Highlighted at Global Healthcare Conferences
15/09/2025
NEW YORK, Sept. 14, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that the successful commercial launch of Ryoncil [...]
AVITA Medical Receives CE Mark for RECELL® GO, Enabling Commercialization Across Europe
15/09/2025
VALENCIA, Calif., Sept. 14, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (“AVITA Medical”, or the “Company”), a leading therapeutic acute wound care company, today announced it has received the [...]
Performer 8 Male Enhancement “Launch” The Herbal Performance Enhancer Non Prescription ED Pills for Men 2025 over the counter by Performer 8
14/09/2025
Performer 8 is a non-prescription male enhancement pills, herbal performance enhancer ED pill for men formulated to support natural stamina, libido, testosterone levels, and sexual NEW YORK , Sept. 14, 2025 (GLOBE [...]
TestoPrime Launch: Advanced Testosterone Booster for Men Over 50’ For Muscle Gain | Does TestoPrime Actually Work?
14/09/2025
Clinicians’ Tested Choice Best Testosterone Booster Supplements to increase testosterone and muscle gain for men: Medically Reviewed and Endorsed by Leading FDA Experts, Now Available over the counter Without [...]
Fangzhou Unveils “XingShi” LLM to Advance AI-Driven Chronic Disease Management
14/09/2025
SHANGHAI, Sept. 14, 2025 (GLOBE NEWSWIRE) -- At its 10th H2H Healthcare Ecosystem Conference, Fangzhou Inc. (“Fangzhou” or the “Company”) (06086.HK), a leader in AI-driven Internet healthcare solutions, announced the [...]
Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting
14/09/2025
WILMETTE, Ill., Sept. 14, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with [...]

Pages